Who Owns Hugo?
Hugo is Medtronic plc's (NYSE: MDT) robotic-assisted surgery system for soft-tissue procedures. Internally developed and first commercialized in 2021, Hugo received FDA clearance for urologic surgery in December 2025 and is in use across more than 35 countries, competing with Intuitive Surgical's da Vinci platform.
Hugo Timeline
GlobalOfficial Website
Who Owns Hugo?
- Parent Company: Medtronic plc
- Ownership Type: Product line
- Company Type: Publicly Traded
- Stock Ticker: NYSE: MDT
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Hugo | Medtronic plc | Product line |
Where to Buy
Disclosure: We may earn commission from purchases
Hugo on AmazonAdvertisement
History of Hugo
- Founded: 2021
- Founders: Medtronic (internal development)
Medtronic began work on a surgical robot after the 2015 Covidien acquisition gave it one of the world's largest surgical instruments businesses. The strategic gap was obvious: Intuitive Surgical's da Vinci had dominated soft-tissue robotic surgery since 2000, and Medtronic's staplers, energy devices, and suturing products were being specified by a competitor's platform.
The company first disclosed the Hugo program publicly around 2019, positioning it as a modular system that could be configured per procedure rather than a single integrated tower. Each of Hugo's four robotic arms sits on an independent cart, a design choice meant to let hospitals move and store components flexibly and to lower the cost of entry versus da Vinci's consolidated architecture.
Hugo earned its first CE Mark in October 2021 for urologic and gynecologic procedures, with a general surgery indication added in October 2022. Commercial rollout ran through Europe, Latin America, the Middle East, Canada, Japan, and Australia, accumulating tens of thousands of procedures across more than 50 procedure types in more than 35 countries.
The U.S. path took longer. Medtronic ran the Expand URO investigational device exemption study, the largest multi-port robotic urology trial completed in the United States, which met its primary safety and effectiveness endpoints. On December 3, 2025, the FDA cleared Hugo for urologic procedures including prostatectomy, nephrectomy, and cystectomy, roughly 230,000 surgeries per year in the U.S. market.
Advertisement
Through 2026 the indication list kept building. Medtronic filed 510(k) submissions for general surgery and gynecology in June 2026, and the FDA cleared the LigaSure RAS Maryland jaw instrument for the system in September 2026. The company also announced a strategic partnership with Cornerstone Robotics in September 2026 to expand its global robotics footprint.
About Medtronic plc
What does Medtronic own?
Medtronic owns the Medtronic device portfolio across cardiovascular, neuroscience, and surgical categories, including named product lines such as Micra, Hugo, Evolut, Mazor, StealthStation, and Valleylab. It no longer owns MiniMed, which became a fully independent public company in October 2026.
Is Medtronic publicly traded?
Yes. Medtronic plc trades on the New York Stock Exchange under ticker MDT and is a component of the S&P 500. It is an Irish-domiciled company that reports as a U.S. domestic issuer.
Who founded Medtronic?
Earl Bakken and his brother-in-law Palmer Hermundslie founded the company in a Minneapolis garage in 1949 as a medical equipment repair business. Bakken invented the first battery-powered wearable pacemaker in 1957.
Advertisement
Where is Medtronic headquartered?
Medtronic is legally domiciled in Galway, Ireland, following the 2015 Covidien acquisition. Its operational headquarters and executive leadership are in Minneapolis, Minnesota.
How many brands does Medtronic own?
Medtronic operates primarily as a master-brand company. Products carry Medtronic branding with trade names like Micra, Hugo, Evolut, and Symplicity. It has fewer than a dozen standalone consumer-facing names.
Who owns Medtronic?
The company is owned by public shareholders with no controlling interest. The largest holders are index investors including Vanguard, BlackRock, and State Street. Geoff Martha serves as Chairman and CEO.
Has Medtronic made major acquisitions recently?
The largest deal in company history was the $42.9 billion Covidien acquisition completed in 2015. More recently it acquired Mazor Robotics (2018, about $1.64 billion) and Affera (2022, about $1 billion). Its biggest recent transaction was a divestiture: the October 2026 separation of MiniMed.
Advertisement
What is Medtronic's revenue?
Medtronic reported FY2026 revenue of $36.4 billion, up 8.4%, its fastest annual growth in ten years. In Q1 FY2027 it posted $9.8 billion in revenue, up 13.7%, and raised full-year guidance.
- Founded: 1949
- Headquarters: Galway, Ireland; operational headquarters Minneapolis, Minnesota, USA
- Company Type: Publicly Traded
- Stock: NYSE: MDT
- Revenue: $36.4 billion (FY2026, ended April 24, 2026)
- Employees: Approximately 95,000
Where Is Hugo Made / Based?
- Headquarters: Minneapolis, Minnesota, USA
- Manufacturing / Operations: United States
Hugo Categories & Tags
Brands Owned by Medtronic plc
Healthcare PharmaceuticalsMedtronic
Owned by Medtronic plc
Flagship brand of Medtronic plc, the world's largest medical device company, covering pacemakers, heart valves, spinal implants, and surgical technology.
medical-devicesmedtechpacemakers
Healthcare PharmaceuticalsMicra
Owned by Medtronic plc
Medtronic's Micra leadless pacemaker family, the world's smallest pacemakers, implanted directly in the heart and used in more than 300,000 patients.
medical-devicespacemakerscardiology
Advertisement
Hugo Ownership: Pros & Cons
Advantages
- +Backed by Medtronic's $36.4 billion revenue base and global surgical salesforce
- +Modular design lowers entry cost versus consolidated robotic platforms
- +Pulls through Valleylab energy and surgical instrument sales per installation
- +Already proven across 35 countries before U.S. launch
- +FDA clearance removes the last major regulatory barrier in the largest market
Considerations
- -Intuitive's installed base and surgeon training ecosystem is a deep moat
- -U.S. clearance currently limited to urology pending general and gynecology submissions
- -Capital equipment sales are cyclical and dependent on hospital budgets
- -Competitive field is crowding with J&J Ottava and lower-cost entrants
- -Platform economics depend on achieving instrument attachment at scale
Frequently Asked Questions About Hugo
Advertisement
Sources & Further Reading
Competitors to Hugo
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Boston Scientific | USA | 1979 | Mass market | Global | All Genders | |
| Stryker | USA | 2004 | Market leader | Global | All Genders | |
| Stryker | USA | 1941 | Market leader | Global | All Genders | |
| Medtronic | USA | 1949 | Mass market | Global | All Genders | |
| Medtronic | USA | 2015 | Mass market | Global | All Genders | |
| Becton Dickinson | USA | 1897 | Mass market | Global | All Genders |
Learn More About Competitors
Healthcare PharmaceuticalsBoston Scientific
Owned by Boston Scientific Corporation
Corporate brand of Boston Scientific Corporation, the Marlborough, Massachusetts medical device maker behind WATCHMAN and FARAPULSE.
medical-devicescardiologymedtech
Healthcare PharmaceuticalsMako SmartRobotics
Owned by Stryker Corporation
Stryker's robotic-arm assisted surgery system for hip and knee replacement, acquired in 2013 and now the leading orthopaedic robotics platform.
surgical-roboticsorthopaedicsmedtech
Healthcare PharmaceuticalsStryker
Owned by Stryker Corporation
Flagship medical technology brand of Stryker Corporation, founded in 1941 and a global leader in orthopaedic implants and surgical equipment.
medical-devicesorthopaedicssurgical-equipment
Healthcare PharmaceuticalsMedtronic
Owned by Medtronic plc
Flagship brand of Medtronic plc, the world's largest medical device company, covering pacemakers, heart valves, spinal implants, and surgical technology.
medical-devicesmedtechpacemakers
Healthcare PharmaceuticalsMicra
Owned by Medtronic plc
Medtronic's Micra leadless pacemaker family, the world's smallest pacemakers, implanted directly in the heart and used in more than 300,000 patients.
medical-devicespacemakerscardiology
Healthcare PharmaceuticalsBD
Owned by Becton, Dickinson and Company
Master brand of Becton, Dickinson and Company, the medical technology company behind Vacutainer, Pyxis, Alaris, and Bard product lines.
medical-devicesmedtechhospital-supplies
Competitive Analysis
Market Positioning: Hugo competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Advertisement
Independent Alternatives to Hugo
Looking for brands with different ownership structures? These similar brands are not owned by Medtronic plc, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsBand-Aid
Owned by Kenvue
American adhesive bandage brand invented in 1921, owned by Kenvue Inc. Band-Aid is the leading adhesive bandage brand in the United States and is sold in more than 100 countries.
wound-careadhesive-bandagefirst-aid
Privately Owned
Band-Aid is privately owned, unlike Hugo which is under a publicly traded parent company.
Healthcare PharmaceuticalsBoston Scientific
Owned by Boston Scientific Corporation
Corporate brand of Boston Scientific Corporation, the Marlborough, Massachusetts medical device maker behind WATCHMAN and FARAPULSE.
medical-devicescardiologymedtech
Publicly Traded
Boston Scientific operates independently without a large parent corporation.
Healthcare PharmaceuticalsStryker
Owned by Stryker Corporation
Flagship medical technology brand of Stryker Corporation, founded in 1941 and a global leader in orthopaedic implants and surgical equipment.
medical-devicesorthopaedicssurgical-equipment
Publicly Traded
Stryker operates independently without a large parent corporation.
Healthcare PharmaceuticalsTylenol
Owned by Kenvue
American brand of pain relief medication and analgesic drugs, flagship product of Kenvue Inc., the consumer health company spun off from Johnson and Johnson in 2023. Kimberly-Clark is acquiring Kenvue in a deal closed on November 2, 2026.
pain-reliefmedicationpharmaceutical
Privately Owned
Tylenol is privately owned, unlike Hugo which is under a publicly traded parent company.
Healthcare PharmaceuticalsWalgreens
Owned by Walgreens Boots Alliance
Walgreens is the largest U.S. pharmacy retail brand, operating roughly 8,000 stores. It went private in August 2025 under Sycamore Partners as a standalone company.
pharmacydrugstoreretail-pharmacy
Privately Owned
Walgreens is privately owned, unlike Hugo which is under a publicly traded parent company.
Healthcare PharmaceuticalsZocdoc
Owned by Zocdoc, Inc.
Online healthcare marketplace where patients find in-network doctors and book appointments instantly, a private New York company valued at $1.8 billion.
healthcareappointment-bookingdigital-health
Privately Owned
Zocdoc is privately owned, unlike Hugo which is under a publicly traded parent company.
Medtronic plc Stock Information
Advertisement
Jobs at Medtronic plc
Latest News About Hugo
Advertisement
Related Articles About Hugo
View more articles
Brand Comparisons
Pfizer vs Johnson & Johnson: Pharma Brand Portfolios Compared
Pfizer and Johnson & Johnson are two of the most recognizable names in healthcare. But their brand portfolios look nothing alike. Here is a complete breakdown of what each company owns, how they got there, and what sets them apart.
Who Brands StaffMar 16, 2026
PharmaceuticalPfizerJohnson And Johnson
Brand Ownership
15 Pharmacy Brands and Their Corporate Parents
CVS spent $69 billion to buy Aetna. Walgreens acquired Boots for $15 billion. Amazon paid $1 billion for PillPack. Here are 15 pharmacy brands, who owns them, and how a once-diverse industry collapsed into two dominant players.
Who Brands StaffFeb 26, 2026
Pharmacy BrandsBrand OwnershipCvs
Brand Ownership
Who Owns Your Vitamins? The Hidden Corporate Parents Behind Supplement Brands
The supplement industry is worth $60+ billion but most brands are owned by pharma giants and food conglomerates. Here is who owns every major vitamin and supplement brand.
Who Brands StaffFeb 5, 2026
VitaminsSupplementsBrand Ownership
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Brandpharmaceutical
Abbokinase
Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.
Brand in Healthcare & Pharmaceuticals
thrombolyticurokinase
Brandrsv-vaccine
Abrysvo
Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.
Brand in Healthcare & Pharmaceuticals
vaccinesmaternal-immunization
Brandspecialty-pharmacy
Accredo
Specialty pharmacy founded in 1996 in Memphis, serving patients with complex and rare conditions as the specialty pharmacy of Evernorth within The Cigna Group.
Brand in Healthcare & Pharmaceuticals
rare-diseaseevernorth